Implant-related Outcomes in the Context of Maxillary Sinus Lifting
Launched by UNIVERSITY OF BERN · Oct 16, 2024
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Patients included in the previous case series study who received tooth replacement therapy with dental implants and maxillary sinus augmentation procedures will be invited for a recall exam at the Department of Oral Surgery to be part of this prospective case series study. During this recall exam, photographs, a comprehensive anamnesis, followed by a standard clinical and digital examination, as well as patient-reported outcomes will be performed.
Primary and secondary outcomes will be measured and collected, and it will be tested whether long-term MBL is smaller than the clinically releva...
Gender
ALL
Eligibility criteria
- Inclusion criteria:
- • Patients who were initially treated at the Department of Oral Surgery and Stomatology between 1997 and 2001
- • Implant placement in the presence of a sinus floor augmentation procedure received during this period
- • Patients involved in a previous cohort study
- Exclusion criteria will be patients:
- • Not able to come to the re-examination
- • Concomitant diseases that compromise the health of this subject during the comprehensive examination (i.e., active severe infectious diseases, liver or kidney dysfunction/failure, currently under treatment)
- • Pregnant women, or unwilling to sign the consent form.
About University Of Bern
The University of Bern, a leading research institution in Switzerland, is dedicated to advancing medical knowledge and improving patient care through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration and cutting-edge research, the university fosters an environment where scientific inquiry and clinical application intersect. Its commitment to ethical standards and patient safety ensures that all trials are conducted with the highest integrity, striving to contribute valuable insights to the global medical community. The University of Bern actively engages in diverse therapeutic areas, aiming to translate research findings into tangible health solutions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bern, , Switzerland
Patients applied
Trial Officials
Emilio Couso-Queiruga, DDS, MS
Study Chair
University of Bern
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported